Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 6/20 | 0.43 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.43 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 3/20 | 0.41 |
| ▸ | MMP9 | P14780 | 3/20 | 0.41 |
| ▸ | MMP2 | P08253 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.40 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6513438 | 1.00 | MMP1 (0.43) | MMP1ITGB1ITGA4MAPTHTT | |
| SCHEMBL6512169 | 0.91 | NPR3 (0.47) | MMP1ANPEPMMP3MMP9MMP2 | |
| SCHEMBL6512165 | 0.91 | NPR3 (0.47) | MMP1ANPEPMMP3MMP9MMP2 | |
| SCHEMBL6513788 | 0.74 | TAS1R3 (0.45) | MMP1ANPEPMMP3MMP9MMP2 | |
| SCHEMBL6513793 | 0.74 | TAS1R3 (0.45) | MMP1ANPEPMMP3MMP9MMP2 | |
| SCHEMBL6511364 | 0.74 | NPR3 (0.45) | MAPTANPEP | |
| SCHEMBL6511358 | 0.74 | NPR3 (0.45) | MAPTANPEP | |
| SCHEMBL6508232 | 0.73 | NPR3 (0.60) | — | |
| SCHEMBL6508225 | 0.73 | NPR3 (0.60) | — | |
| SCHEMBL15251955 | 0.72 | HTT (0.58) | MMP1MAPTHTTANPEPMMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005003103-A2 | 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | ASTRAZENECA AB (SE) | 2005-01-13 | — | — | WO | disclosed |